Literature DB >> 9468716

Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients.

G F Harding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9468716      PMCID： PMC2665458     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Study is needed of visual field defects associated with any long term antiepileptic drug.

Authors:  G P Rao; F A Fat; G Kyle; J P Leach; D W Chadwick; M Batterbury
Journal:  BMJ       Date:  1998-07-18

2.  Visual field constriction and electrophysiological changes associated with vigabatrin.

Authors:  Dorothea Besch; Anne Kurtenbach; Eckart Apfelstedt-Sylla; Bettina Sadowski; Dieter Dennig; Christiane Asenbauer; Eberhart Zrenner; Ulrich Schiefer
Journal:  Doc Ophthalmol       Date:  2002-03       Impact factor: 2.379

Review 3.  Treatment of partial seizures in childhood : an overview.

Authors:  Giangennaro Coppola
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Behavioural effects of the new anticonvulsants.

Authors:  F M Besag
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 5.  Visual field defects and other ophthalmological disturbances associated with vigabatrin.

Authors:  S J Spence; R Sankar
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.